好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Oral Treatment with Purified Polysaccharide A (PSA) of Human Commensal Bacteroides fragilis Protects Against Experimental CNS Demyelinating Disease
MS and Related Diseases
(-)
212
Authors/Disclosures
Javier Ochoa-Reparaz, PhD (Eastern Washington University) No disclosure on file
No disclosure on file
No disclosure on file
Sakhina Begum-Haque, PhD (Dartmouth Med School) No disclosure on file
No disclosure on file
Lloyd H. Kasper, MD (Dartmouth Medical School) No disclosure on file
M. M. Paz Soldan, MD, PhD (Mayo Clinic) Dr. Paz Soldan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Paz Soldan has received research support from National Institutes of Health. The institution of Dr. Paz Soldan has received research support from National Multiple Sclerosis Society. The institution of Dr. Paz Soldan has received research support from Western Institute for Biomedical Research. The institution of Dr. Paz Soldan has received research support from Biogen. The institution of Dr. Paz Soldan has received research support from Novartis. The institution of Dr. Paz Soldan has received research support from Clene Nanomedicine.